Please login to the form below

cost-effectiveness

This page shows the latest cost-effectiveness news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca's Lynparza recommended by NICE for breast and prostate cancer

2020. However, NICE had not recommended the treatment for breast and prostate cancer patients until now due to concerns over its cost-effectiveness. ... process. "Innovative oncology medicines such as olaparib often show effectiveness across multiple

Latest news

NICE publishes draft guidance not recommending Ipsen’s Cabometyx for thyroid cancer

meaning cost-effectiveness estimates are ‘unclear’. ... The decision is also surprising due to the fact that cabozantinib fell within NICE’s cost-effectiveness range, especially as it was acknowledged by the NICE committee that there is an
MSD’s Keytruda to be made available in England for advanced cervical cancer patients

The CDF pays for cancer treatments while data is collected on their clinical effectiveness, meaning patients can have earlier access to treatments while further evidence is generated. ... However, to ensure the best use of limited public funding, we need
NICE sees ‘promise’ in four UTI tests that could help in fight against AMR

on their clinical and cost-effectiveness is generated.
NICE publishes final draft guidance recommending three COVID-19 treatments

The medicines have shown promise in treating COVID-19 and been found cost-effective. ... Helen Knight, director of medicines evaluation at NICE, said: “NICE is the first health technology assessment body in the world to look at the clinical- and
AstraZeneca’s Evusheld not recommended by NICE for COVID-19 prevention

The agency said there is not enough evidence of the drug’s effectiveness against current variants. ... Knight added: “The rapidly evolving nature of COVID-19 means we need to have a way of establishing the cost-effectiveness of existing medicines

More from news
Approximately 3 fully matching, plus 597 partially matching documents found.

Latest Intelligence

Strategic behaviour

Yet, for all its complexity and cost, the effectiveness of this strategising is not built on technical or processual efficacy but on intensely human frailties and foibles. ... Counterproductive behaviours:Those individual behaviours that explicitly
Are smart deals a clever solution to UK market access?

For pharma, this enables expedited access via alternative funding, along with the opportunity to gather additional evidence to address any uncertainties regarding clinical and cost- effectiveness.
The fight against antimicrobial resistance

to £30, 000 per QALY that the National Institute for Health and Care Excellence (NICE) uses to measure cost-effectiveness of new drugs. ... Practices can make further cost savings by investing in a platform that can test for other biomarkers as well as
Health technology assessments: understanding the global landscape and considerations for drug development

The National Institute for Health and Care Excellence (NICE) in the UK has long used cost- effectiveness assessments as the centre of its HTA, price and reimbursement process. ... Drug value assessment timelines can differ tremendously in
Pharma’s authentic proof of purpose influences decisions among HCPs and payers

Payers, a step or two away from direct patient care, aligned their own purpose to being the guardians of efficient and cost-effective care. ... Those in France and Spain aligned their purpose more to ensuring efficiency and cost- effectiveness of care.

More from intelligence
Approximately 0 fully matching, plus 72 partially matching documents found.

Latest appointments

Former NICE chair joins board of biotech

Sir Michael Rawlins joins board of Intra-Cellular Therapeutics. The former chair of England's cost-effectiveness body for medicines, Sir Michael Rawlins, has made a contentious move to the US ... His expertise in the cost-effectiveness of new
Executive changes at Teva as community and institutional affairs division launched

Referencing Teva's previous record in compliance, Dr De Notaristefani said: “We will continue this practice as we begin to set the industry standard for regulatory compliance, customer service and cost ... effectiveness.”. Teva launches community and

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Practical advice for Early Scientific Advice (ESA) in HTA submissions

Payers must take into consideration not only the clinical efficacy of a drug, but also its safety profile, side effects, and cost-effectiveness, among other factors. ... Health Technology Assessment (HTA) is an important tool for decision-makers when it
Aycan Hassan-Walker appointed as Regional Director, Europe of Nucleus Global

What is your vision for the Nucleus Global EU region? Digital transformation was already a focus for the pharmaceutical industry to improve, for instance, healthcare solutions, clinical trials, patient care, ... effectiveness and efficiencies before the
OPEN VIE and Pharmerit Bring the Best of Both Worlds to Virtual ISPOR Europe 2020

access. ON DEMAND SESSIONS:. Cost-effectiveness Modelling of Complex Pathways. Presenter: Elisabeth Fenwick.
How can pharma align its brand strategy with the NHS Reset?

New pathways. In the past, cost-effectiveness was the key priority for the NHS when buying drugs.
UK vs US: what makes a successful immunisation programme?

In the US cost effectiveness is considered, but the ACIP does not rely heavily upon it. ... As a result, the consideration of cost-effectiveness is a key difference in the vaccine schedules between the US and UK.

More from PMHub
Approximately 0 fully matching, plus 22 partially matching documents found.

Subscribe to our email news alerts

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

No results were found

PMHub

Add my company

11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

The 17th World Congress on Controversies in Neurology: This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success: In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge: Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...

Email:
Password:

Please login to the form below

cost-effectiveness

Subscribe to our email news alerts

Quick links